Drug Shortage Report for VEPESID

Last updated on 2019-04-18 History
Report ID 70228
Drug Identification Number 00616192
Brand name VEPESID
Common or Proper name Etoposide
Company Name BRISTOL-MYERS SQUIBB CANADA
Active Ingredient(s) ETOPOSIDE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 20
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-07-01
Actual start date
Estimated end date 2019-07-01
Actual end date
Shortage status Anticipated shortage
Updated date 2019-04-18
Company comments Stock is being allocated. Generics on back order for Etoposide IV has increased demand for Vepesid capsules.
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-04-18 French Compare
v17 2019-04-18 English Compare
v16 2019-03-04 French Compare
v15 2019-03-04 English Compare
v14 2019-03-04 French Compare
v13 2019-03-04 English Compare
v12 2019-03-04 French Compare
v11 2019-03-04 English Compare
v10 2019-03-04 French Compare
v9 2019-03-04 English Compare
v8 2019-02-13 French Compare
v7 2019-02-13 English Compare
v6 2019-01-22 French Compare
v5 2019-01-22 English Compare
v4 2019-01-22 French Compare
v3 2019-01-22 English Compare
v2 2018-12-20 French Compare
v1 2018-12-20 English Compare